About Group Pharma
Group Pharma is a company based in Mumbai (India) founded in 1980 was acquired by Jagsonpal in September 2026. It operates as a B2C and B2B. The company has 739 employees. Group Pharma offers products and services including Oral Care Products and Multi-Speciality Products. Group Pharma operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter Mumbai, India
- Employees 739
- SectorsHealthcare
- Phone•••• ••••
- Website grouppharma.com
- Social LinkedIn X Facebook YouTube
- Acquired by Jagsonpal (Sep 2026)
- Legal Name Group Pharmaceuticals Limited
- Date of Incorporation 24 Jul, 1980
- Jurisdiction Thane, Maharashtra, India
Associated legal entities of Group Pharma
Group Pharma operates through Group Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Group Pharmaceuticals Limited CIN U24239MH1980PLC022889 | Active | 24 Jul 1980 | Thane, Maharashtra | ₹168 Cr | 739 | 9 | View details |
Products & Services of Group Pharma
Group Pharma offers a comprehensive portfolio of products and services, including Oral Care Products and Multi-Speciality Products.
Specialized products for treating dental and oral conditions with innovative formulations.
Cough syrups and anti-bacterial gels for general health and wellness needs.
Apps and channels of Group Pharma
its YouTube channel Group Pharma has 9.07K subscribers and 30 videos.
Videos from Group Pharma
The most watched videos on Group Pharma's YouTube channel, Group Pharma (9.07K subscribers). Click a video to play it here.
More on Group Pharma.
Investors in Group Pharma
Group Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Jagsonpal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Traditional company manufacturing bulk drugs and finished formulations | 1964 | jagsonpal.com | Delhi, India |
Investor details for Group Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Group Pharmaceuticals Limited (Group Pharma)
Group Pharmaceuticals Limited is the primary company behind Group Pharma. The board of Group Pharmaceuticals Limited currently have 7 directors; the longest-serving is Ann Valerie Sunil Attavar, appointed in 2008. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ann Valerie Sunil Attavar DIN 00091390 | Whole-time director | 15 Sep 2008 | 18 yrs | Group Pharmaceuticals Limited |
| Sunil Attavar Cajaten DIN 00091347 | Nodal Officer | 17 Sep 2019 | 7 yrs | Group Pharmaceuticals Limited |
| Deepak Mohan DIN 07825780 | Managing Director | 24 May 2024 | 2 yrs 4 mo | Group Pharmaceuticals Limited |
| Jacob Mathew DIN 00996521 | Director | 24 May 2024 | 2 yrs 4 mo | Group Pharmaceuticals Limited |
| Srinivas Gogineni DIN 07231858 | Director | 08 Aug 2024 | 2 yrs 2 mo | Group Pharmaceuticals Limited |
| Nandipur Kallappa Dilip DIN 05221838 | Director | 08 Aug 2024 | 2 yrs 2 mo | Group Pharmaceuticals Limited |
| Nikhil Kaushik DIN 00040403 | Additional Director | 29 Sep 2025 | 1 yr | Group Pharmaceuticals Limited |
Financials of Group Pharma
Figures of Group Pharmaceuticals Limited, the primary company behind Group Pharma, for FY 2025. Revenue was ₹168 Cr (+10% year on year). Net profit was ₹10.44 Cr (6% margin). EBITDA was ₹15.78 Cr (9% margin). Revenue has grown at a compounded annual rate of +9% over three years and +6% over five years.
- ₹168 CrRevenue · FY 2025 · +10% YoY
- ₹10.44 CrNet profit · 6% margin
- ₹15.78 CrEBITDA · 9% margin
- ₹12.68 CrPaid-up capital
- 739Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Group Pharmaceuticals Limited are on its company page.
Detailed financial statements for Group Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Group Pharma
2 dated milestones of Group Pharma across 46 years, from founding to its latest funding, stage changes and deals.
- Founded Group Pharma is founded.
- Exit Acquired by Jagsonpal.
Competitors of Group Pharma
Group Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmaron.com | 2003 | Beijing, China | $320M | 476 | Drug discovery and development services for small molecules are provided. | |
| lonza.com | 1897 | Basel, Switzerland | $100,000 | 14,500 | CDMO services for pharma, biotech, and specialty ingredients are provided. | |
| pfizer.com | 1849 | New York, United States | $8M | – | Pharmaceutical products for treating multiple diseases are provided. | |
| boehringer-ingelheim.com | 1885 | – | – | 31 | Generic drugs and clinical research services are provided globally. | |
| labconnect.com | 2002 | Johnson, United States | $28.5M | – | Laboratory testing, clinical trial research, and biopharma services are provided. | |
| dotmatics.com | 2005 | – | $11.34M | 512 | AI powered scientific data management and workflow automation solutions | |
| ainos.com | 1986 | San Diego, United States | – | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. | |
| biomatter.ai | 2018 | Vilnius, Lithuania | $7.73M | – | Provider of synthetic biology and AI-based technology for generative protein design | |
| betadrugslimited.com | 2005 | Panchkula, India | – | 637 | Developer of therapeutics for oncology and dermatology |
Detailed competitors of Group Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Group Pharma
The website of Group Pharma (grouppharma.com) receives about 7.8K visits a month.
- Monthly visits7.8K
▼ 19.5% vs previous month
Latest news on Group Pharma
Complete news archive for Group Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Group Pharma
10 companies that operate in the same segment as Group Pharma (Dental Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Custom 3D printed dental aligners are developed for teeth straightening. | 2017 | New York, New York, United States | USD 147.78 M | – | – | |
Invisalign clear aligners and dental products are developed. | 1997 | Tempe, Arizona, United States | USD 101 M | – | 1,051 | |
Provider of 3D ear scanning systems | 2000 | Copenhagen, Denmark | USD 36.01 K | – | 1 | |
Dental implants and regenerative dentistry products are developed. | 1954 | Basel, Basel-stadt, Switzerland | – | USD 3.29 B | – | |
Optical equipment for micron-level surface geometry capture is offered. | 2011 | Waltham, Massachusetts, United States | USD 16.22 M | – | – | |
Dental implant solutions are provided for patients and professionals. | 2000 | Harrogate, United Kingdom | USD 30.01 M | – | – | |
Dental implants and biomaterials are developed by Keystone Dental. | 2006 | Burlington, Vermont, United States | USD 86.24 M | – | – | |
Therapy devices and software for treating tooth decay are developed. | 2006 | Laguna Hills, California, United States | USD 285.41 M | USD 28.55 M | 131 | |
Invisible braces and oral care products are developed and provided. | 2018 | Singapore, Singapore | USD 55.1 M | – | – | |
Implants for dental and spine treatments are developed. | 2022 | Westminster, United States | – | USD 449.75 M | 1,770 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Group Pharma
Group Pharma was founded in 1980.
Group Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Group Pharma has 739 employees.
The primary company behind Group Pharma, Group Pharmaceuticals Limited, reported revenue of ₹168 Cr for FY 2025, up 10% year on year.
Group Pharmaceuticals Ltd focuses on developing, manufacturing, marketing, and exporting specialized oral care and healthcare products. They cater to consumers with specific dental and oral conditions, using innovative formulations and maintaining high standards like ISO and cGMP certifications. Based in India, with facilities in Mumbai, Bengaluru, and other areas, they serve over 60 countries through a workforce of over 800 employees. Their approach emphasizes ethical standards, RD, and continuous product improvement to meet global health needs.
Group Pharma offers Oral Care Products and Multi-Speciality Products.
Group Pharma has 1 investor. Key investors include Jagsonpal.
Group Pharma operates through Group Pharmaceuticals Limited.
Yes. Group Pharma was acquired by Jagsonpal in September 2026.
The legal entities of Group Pharma currently have 8 directors, including Deepak Mohan, Sunil Attavar Cajaten, Ann Valerie Sunil Attavar and others.